Interstitial lung disease
Conditions
Interventions
Room air
High-flow nasal cannula(FiO2 0.21, Flow 40L/min)
High-flow nasal cannula(FiO2 0.6, Flow 40L/min)
Sponsors
Seirei Mikatahara General Hospital, Dept. of Rehabilitation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, Patients with stable interstitial lung disease who are hospitalized for the purpose of introducing steroids, pirfenidone and nintedanib 2, Age at the time of consent acquisition is over 40 years old and under 80 years old 3, Informed consent can be obtained in writing from the person
Exclusion criteria
Exclusion criteria: 1, Having collagen disease, neuromuscular disease, or orthopedic disease that may affect exercise tolerance assessment at enrollment 2, Requires antiarrhythmic treatment 3, Clinically complicated with severe pulmonary antihypertension 4, Researcher decides that it is not appropriate to register for this exam 5, Patients with malignant tumors whose recurrence has not been confirmed for over 3 years 6, Home oxygen therapy introduction patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endurance time of bicycle ergometer according to High-flow nasal cannula setting condition | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective dyspnea while performing a bicycle ergometer with High-flow nasal cannula settings | — |
Countries
Japan
Contacts
Public ContactYanagita Yorihide
Seirei Mikatahara General Hospital Dept. of Rehabilitation
Outcome results
None listed